## Abstract Thirtyβtwo patients with hepatic metastases colorectal carcinoma were treated with hepatic artery infusion (HAI) employing 5βfluorouracil (5βFU) and mitomycinβC (mitoβC). Catheters were placed percutaneously via the femoral artery. Two schedules were employed: (I) 5βFU 1,200 mg/m^2^ IA
Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma
β Scribed by J. Wils; J. Schlangen; A. Naus
- Publisher
- Springer
- Year
- 1984
- Tongue
- English
- Weight
- 319 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty-seven patients with measurable liver metastases from colorectal carcinoma were entered on a protocol of intermittent hepaticartery infusion (HAI) of 5-fluorouracil(5-FU) followed by consolidation with hepatic irradiation. Five partial responses were observed in 23 evaluable patients. Median d
Background. Regional therapy for colorectal liver metastases aimed at prolonging survival has not been tested fully in a randomized trial with untreated control subjects. This study explored the efficacy of temporary hepatic artery occlusion followed by intraportal infusion of 5-fluorouracil[5-FU) a